This year, the Center for Medicare and Medicaid Services (CMS) has expressed its firm commitment to improving blood glucose management, an area often overlooked in inpatient care. For health system executives who have not yet noticed, there are many reasons why they need to start paying attention to blood glucose quality indicators.
As part of the CMS, it was announced that blood glucose management will be a key indicator of patient safety Annual adjustment of hospitalization payment policy, With the updated rules of its Inpatient Quality Report (IQR) plan.Quality reporting procedures serve Two purposes: “Promote quality improvement through measurement and transparency” and “encourage hospitals and clinicians to improve the quality and cost of inpatient care provided to all patients.”
As CMS pushes the industry towards more value-based arrangements and risk sharing, these rules are part of an effort to identify areas of quality improvement that can have a significant impact on the safety and cost of overall inpatient care. This is why blood sugar management has become the focus this year.
In fact, two of the three new electronic clinical quality indicators (eCQM) CMS launched this year involve blood glucose management.An overview measurement Long-term untreated hyperglycemia Hospital ratio, while the other aims to measure preventable Severe hypoglycemia Due to adverse drug reactions.
The new eCQM pays much attention to blood glucose indicators because they are key indicators of patient safety in hospitals.The short-term and long-term negative effects of high or low blood sugar on people are Well documentedFor hospitals, more and more evidence shows how abnormal blood glucose stability affects the quality and cost of care.
Although it is generally believed that monitoring and treating blood glucose is only important for diabetic patients, this is not the case.
The fact is, about two-fifths Admitted patients There is hyperglycemia, and one third of them have no history of diabetes. In addition to the number of people with persistent but undiagnosed blood sugar management problems, critically ill patients experience transient, stress-induced hyperglycemia after surgery.Moreover Hundreds of drugs A person may have received a prescription that is known to affect insulin resistance during hospitalization, which in turn affects blood sugar levels.
The need for proper blood glucose management is not limited to a single disease state and specialty, even a hospital unit. However, even if blood sugar is an underlying factor that may affect the outcome of many diseases that a person receives in the hospital, it is usually not treated as urgently or effectively as it should be. Since providers tend to focus on the main reasons for patients’ admission, while experts only focus on their clinical expertise, blood glucose management has historically been low in the priority list.
Most importantly, many nurses and doctors do not have the knowledge or skills needed to properly treat abnormal blood sugar. Therefore, in order to help calculate insulin doses, they rely on outdated methods that require manual calculations and cannot personalize treatment or solve the workflow challenges of correct timing of blood glucose checks and dose adjustments.These common methods run counter to recommendations made by the American Diabetes Association (ADA) and other organizations Personalized written or computerized dosing regimen As a standard of care.
The personalized treatment recommended by the ADA and other institutions will be adjusted regularly as the needs of patients change, because at present, In acute care settings, 16.3% of false reports of high-alert drugs involved insulin, More than any other drug type. But on the other hand, when insulin is used effectively to help patients maintain their target blood sugar, it can save lives and increase their morbidity and mortality.
The study also shows that keeping patients within the target range, using clinically validated protocols, allowing the use of safety barriers for personalized care, can be Reduce the 30-day readmission rate by as much as 68% with Shorten your stay by up to 3.2 daysNaturally, being able to improve patient outcomes faster-and prevent them from returning to the hospital for the same conditions-will also have a positive impact on the total cost of care.In fact, a hospital studying the financial impact of improving patient blood glucose management recorded cost savings as high as $9 million in the first year.
An exciting benefit of the new CMS reporting measures is that although they do not actually set standards or benchmarks for good blood glucose management, having consistent industry-wide measures will enable hospitals to understand how they compare to other similar hospitals .
Although every hospital should hope to reduce the incidence of hyperglycemia and hypoglycemia-for many of the reasons discussed above-most hospitals have not established blood glucose KPIs for benchmarking to let them know how well or how good their performance is. How far needs to be improved. The first step is to track consistent metrics, and CMS is creating incentives to encourage hospitals to follow. Hospitals that do not comply with the reporting requirements will lose part of the payments they paid for Medicare patients—and no one wants to see the income of their largest payer decrease.
Over the past few decades, there has been more and more evidence about the impact of blood glucose management on the cost and quality of inpatient care, and it has become difficult to ignore. This recognition of CMS is a turning point, it has already arrived, and hospitals that have not yet paid attention to blood sugar management will start now.
